Evidence map›Paper›PMID 34677942›Full record

ReviewACS synthetic biology2021

Directed Evolution in Drops: Molecular Aspects and Applications.

Aitor Manteca, Alejandra Gadea, David Van Assche, Pauline Cossard, Mélanie Gillard-Bocquet, Thomas Beneyton, C Axel Innis, Jean-Christophe Baret

Abstract readReview
In one paragraph

Review in ACS synthetic biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Confocal Absorbance-Activated Droplet Sorting (cAADS) for Enzyme Engineering.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  2. Article
  3. Article
  4. Cross-chiral exponential amplification of an RNA enzyme.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Cell-Free Production Systems in Droplet Microfluidics.Advances in biochemical engineering/biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aitor MantecaUniv. Bordeaux, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, ARNA, U1212, UMR 5320, Institut Européen de Chimie et Biologie, F-33600 Pessac, France.ORCID 0000-0002-8650-0465
Alejandra GadeaUniv. Bordeaux, CNRS, CRPP, UMR 5031, F-33610, Pessac, France.
David Van AsscheUniv. Bordeaux, CNRS, CRPP, UMR 5031, F-33610, Pessac, France.
Pauline CossardUniv. Bordeaux, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, ARNA, U1212, UMR 5320, Institut Européen de Chimie et Biologie, F-33600 Pessac, France.
Mélanie Gillard-BocquetUniv. Bordeaux, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, ARNA, U1212, UMR 5320, Institut Européen de Chimie et Biologie, F-33600 Pessac, France.
Thomas BeneytonUniv. Bordeaux, CNRS, CRPP, UMR 5031, F-33610, Pessac, France.
C Axel InnisUniv. Bordeaux, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, ARNA, U1212, UMR 5320, Institut Européen de Chimie et Biologie, F-33600 Pessac, France.ORCID 0000-0003-3153-9490
Jean-Christophe BaretUniv. Bordeaux, CNRS, CRPP, UMR 5031, F-33610, Pessac, France.ORCID 0000-0003-2048-8317

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The process of optimizing the properties of biological molecules is paramount for many industrial and medical applications. Directed evolution is a powerful technique for modifying and improving biomolecules such as proteins or nucleic acids (DNA or RNA). Mimicking the mechanism of natural evolution, one can enhance a desired property by applying a suitable selection pressure and sorting improved variants. Droplet-based microfluidic systems offer a high-throughput solution to this approach by helping to overcome the limiting screening steps and allowing the analysis of variants within increasingly complex libraries. Here, we review cases where successful evolution of biomolecules was achieved using droplet-based microfluidics, focusing on the molecular processes involved and the incorporation of microfluidics to the workflow. We highlight the advantages and limitations of these microfluidic systems compared to low-throughput methods and show how the integration of these systems into directed evolution workflows can open new avenues to discover or improve biomolecules according to user-defined conditions.

Indexed as

AnimalsDirected Molecular EvolutionDNAHigh-Throughput Screening AssaysHumansMicrofluidic Analytical TechniquesMicrofluidicsRNADNARNAantibodyaptamerdirected evolutiondroplet microfluidicsenzymemolecular engineering

Identifiers

PMID34677942
PMCPMC8609573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.